[HTML][HTML] Safety assessment of conventional and biological systemic therapy in older adults with psoriasis, a real-world multicentre cohort study

ELM Ter Haar, EE Ten Bruin… - Acta Dermato …, 2022 - ncbi.nlm.nih.gov
Optimal selection of systemic therapy in older adults with psoriasis can be challenging, due
to sparse evidence-based guidance. This multicentre retrospective study investigated the …

Safety Assessment of Conventional and Biological Systemic Therapy in Older Adults with Psoriasis, a Real-world Multicentre Cohort Study.

ELM Ter Haar, EE Ten Bruin, EE Bronkhorst… - Acta Dermato …, 2022 - europepmc.org
Optimal selection of systemic therapy in older adults with psoriasis can be challenging, due
to sparse evidence-based guidance. This multicentre retrospective study investigated the …

Safety Assessment of Conventional and Biological Systemic Therapy in Older Adults with Psoriasis, a Real-world Multicentre Cohort Study

ELM Ter Haar, EE Ten Bruin… - Acta dermato …, 2022 - pubmed.ncbi.nlm.nih.gov
Optimal selection of systemic therapy in older adults with psoriasis can be challenging, due
to sparse evidence-based guidance. This multicentre retrospective study investigated the …

[PDF][PDF] Safety Assessment of Conventional and Biological Systemic Therapy in Older Adults with Psoriasis, a Real-world Multicentre Cohort Study

ELM ter Haar, EET Bruin, EM Bronkhorst, RJ Borgonjen… - 2022 - repository.ubn.ru.nl
A multicentre retrospective cohort study was performed to assess disease and treatment
patterns in older adults (≥ 65 years) with psoriasis (Geriatric Psoriasis Patterns (GEPPA) …

[PDF][PDF] Safety Assessment of Conventional and Biological Systemic Therapy in Older Adults with Psoriasis, a Real-world Multicentre Cohort Study

ELM TER HAAR, EE TEN BRUIN, EM BRONKHORST… - Age - scholar.archive.org
A multicentre retrospective cohort study was performed to assess disease and treatment
patterns in older adults (≥ 65 years) with psoriasis (Geriatric Psoriasis Patterns (GEPPA) …

Safety Assessment of Conventional and Biological Systemic Therapy in Older Adults with Psoriasis, a Real-world Multicentre Cohort Study

ELM ter Haar, EE ten Bruin… - Acta Dermato …, 2022 - medicaljournalssweden.se
Optimal selection of systemic therapy in older adults with psoriasis can be challenging, due
to sparse evidence-based guidance. This multicentre retrospective study investigated the …

[PDF][PDF] Safety Assessment of Conventional and Biological Systemic Therapy in Older Adults with Psoriasis, a Real-world Multicentre Cohort Study

ELM TER HAAR, EE TEN BRUIN, EM BRONKHORST… - Age - pdfs.semanticscholar.org
A multicentre retrospective cohort study was performed to assess disease and treatment
patterns in older adults (≥ 65 years) with psoriasis (Geriatric Psoriasis Patterns (GEPPA) …

Safety Assessment of Conventional and Biological Systemic Therapy in Older Adults with Psoriasis, a Real-world Multicentre Cohort Study.

ELM TER HAAR, EE TEN BRUIN… - Acta Dermato …, 2022 - search.ebscohost.com
Optimal selection of systemic therapy in older adults with psoriasis can be challenging, due
to sparse evidence-based guidance. This multicentre retrospective study investigated the …

[引用][C] Safety Assessment of Conventional and Biological Systemic Therapy in Older Adults with Psoriasis, a Real-world Multicentre Cohort Study

ELM TER HAAR, EE TEN BRUIN, EM BRONKHORST… - Age - europepmc.org
A multicentre retrospective cohort study was performed to assess disease and treatment
patterns in older adults (≥ 65 years) with psoriasis (Geriatric Psoriasis Patterns (GEPPA) …